Search Results - "SCARAMUCCI, J"

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis by RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Get full text

Energy from sugarcane bagasse under electricity rationing in Brazil: a computable general equilibrium model by Scaramucci, Jose A., Perin, Clovis, Pulino, Petronio, Bordoni, Orlando F.J.G., da Cunha, Marcelo P., Cortez, Luis A.B.

“…In the midst of the institutional reforms of the Brazilian electric sectors initiated in the 1990s, a serious electricity shortage crisis developed in 2001. As…”
Get full text

Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFNβ-1a) products administered intramuscularly in healthy male and female volunteers by ALAM, J, GOELZ, S, RIOUX, P, SCARAMUCCI, J, JONES, W, MCALLISTER, A, CAMPION, M, ROGGE, M

Get full text

Teaching about AIDS in public schools: characteristics of early adopter communities in Massachusetts by Howland, J, Baker, D, Johnson, J, Scaramucci, J

Get more information

Pharmacokinetics and Pharmacodynamics of Interferon Beta-1a (IFN??-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration by Alam, John, McAllister, Arthur, Scaramucci, James, Jones, Wendy, Rogge, Mark

Get full text

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) by Rudick, R A, Simonian, N A, Alam, J A, Campion, M, Scaramucci, J O, Jones, W, Coats, M E, Goodkin, D E, Weinstock-Guttman, B, Herndon, R M, Mass, M K, Richert, J R, Salazar, A M, Munschauer, 3rd, F E, Cookfair, D L, Simon, J H, Jacobs, L D

“…Interferon beta is an effective treatment for relapsing multiple sclerosis (MS). As with other protein drugs, neutralizing antibodies (NAB) can develop that…”
Get full text

Carcinoma in situ of the cervix: a report of fifty-one cases, with consideration of minimal therapy by SCARAMUCCI, J C, FENNELL, Jr, R H, HEPP, J A

Get more information

Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis by Herndon, RM, Jacobs, LD, Coats, ME, Goodkin, DE, Mass, MK, Richert, JR, Rudick, RA, Waubant, EL, Weinstock-Guttman, B, Scaramucci, JO, Burnett, BK, Jones, WE, Simonian, NA

“…Abstract In a phase III, double-blind, placebo-controlled, 2-year clinical trial, interferon beta-1a (IFN-β-1a, Avonex) treatment significantly delayed…”
Get full text